MBX
MBX Biosciences, Inc. Common Stock
NASDAQ · USHealthcareBiotechnology
$60.14-4.42%
Price as of Jul 20, 2026
MBX valuation
MBX Biosciences, Inc. Common Stock valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.54x
- Price / sales
- —
- Price / cash flow
- -36.95x
Enterprise value
- Enterprise value
- $2.4B
- EV / sales
- —
- EV / EBITDA
- -28.05x
- EV / EBIT
- -24.53x
- Market cap
- $2.9B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.